Other Information
+Added: Departure of Directors or Certain Officers;
+Added: Election of Directors;
+Added: Appointment of Certain Officers;
+Added: Compensatory Arrangements of Certain Officers
+Added: On June 1, 2025, the Company entered into a Consulting Agreement with Kujo Capital, LLC, a Wyoming limited liability company, pursuant to which Kujo Capital, LLC agrees to make available the services of Mr.
+Added: Al Kucharchuk as Chief Financial Officer of the Company on a consultancy basis.
+Added: Effective as of August 11, 2025, Mr.
+Added: Tim Rotolo resigned as the Chief Financial Officer of the Company and the board of directors of the Company appointed Mr.
+Added: Al Kucharchuk to serve as the Chief Financial Officer of the Company, to fill the vacancy created by Mr.
+Added: Tim Rotolo’s resignation.
+Added: Kucharchuk serves as Chief Financial Officer of Cero Therapeutics, Inc (Nasdaq:CERO).
+Added: Previously, he has served as the Chief Financial Officer of Theralink Technologies, Inc.
+Added: (“Theralink”) (OTCMKTS:
+Added: THER) from May 2023 until May 2024 also served as President and Chief Financial Officer of Theralink from February 2016 until June 2020, as Chief Executive Officer of Theralink from November 2019 until June 2020 and as Acting Chief Financial Officer of Theralink from June 2020 to September 2020.
+Added: He has served on the Board of Directors of Theralink since June 2020.
+Added: Kucharchuk also served as Chief Executive Officer and Chief Financial Officer of OncBioMune, Inc.
+Added: (“OBMP”) prior to Theralink’s acquisition of OBMP.
+Added: Kucharchuk served as the Chairman and Chief Operating Officer Adhera Therapeutics, Inc.
+Added: ATRX) from July 2020 until September 2022 and its Chief Operations Officer from October 2022 to September 2024.
+Added: Kucharchuk is a graduate of Louisiana State University and Tulane University’s Freeman School of Business, where he earned an MBA with a Finance Concentration.
Insider Trading Arrangements and Policies
−Removed: During the three months ended March 31, 2025, none of the Company’s directors or officers (as defined in Rule 16a-1(f)
+Added: During the six months ended June 30, 2025, none of the Company’s directors or officers (as defined in Rule 16a-1(f)
of the Exchange Act) adopted or terminated a “Rule 10b5-1
4 unchanged sentences
Amended and Restated Memorandum and Articles of Association of the Company, dated December 23, 2024 (filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on December 26, 2024 and incorporated by reference herein).
+Added: Consulting Agreement, dated June 1, 2025.
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
+Added: Certification of Principal Financial and Accounting Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
Certification of Principal Executive Officer Pursuant to 18 U.S.C.
Section 1350, as adopted Pursuant to Section 906 of the Sarbanes- Oxley Act of 2002
+Added: Certification of Principal Financial and Accounting Officer Pursuant to 18 U.S.C.
+Added: Section 1350, as adopted Pursuant to Section 906 of the Sarbanes- Oxley Act of 2002
Inline XBRL Instance Document — the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
4 unchanged sentences
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
−Removed: The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, formatted in Inline XBRL.
+Added: The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, formatted in Inline XBRL.
Filed herewith.
2 unchanged sentences
RANGE CAPITAL ACQUISITION CORP.
−Removed: Date May 15, 2025
+Added: Date August 14, 2025
/s/ Tim Rotolo
−Removed: Chief Executive Officer and Chief Financial Officer (Principal Executive Officer, Principal Financial and Accounting Officer)
+Added: Chief Executive Officer
+Added: (Principal Executive Officer)
+Added: /s/ Al Kucharchuk
+Added: Al Kucharchuk
+Added: Chief Financial Officer
+Added: (Principal Financial and Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.